BiondVax Pharmaceuticals (NASDAQ:BVXV) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance BiondVax Pharmaceuticals stock opened at $1.31 on Thursday. The stock’s 50 day moving average price is $1.37 and its 200 day moving average price […]

Related Keywords

Israel , ,Exchange Commission ,Max Planck Society ,Institutional Investors Weigh In On Biondvax Pharmaceuticals ,Biondvax Pharmaceuticals Ltd ,Nasdaq ,University Medical Center ,Biondvax Pharmaceuticals Stock Performance ,News Ratings For Biondvax Pharmaceuticals Daily ,Sabby Management ,Biondvax Pharmaceuticals ,Free Report ,Vax Pharmaceuticals ,Get Free Report ,Vax Pharmaceuticals Ltd ,Biondvax Pharmaceuticals Daily ,Nasdaq Bvxv ,Bvxv ,Medical ,Initiated Coverage ,Stocknews Com ,